Impact of drug-eluting stent length on outcomes less is more...more or less

JACC Cardiovasc Interv. 2010 Feb;3(2):189-90. doi: 10.1016/j.jcin.2009.12.006.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Coronary Artery Disease / mortality
  • Coronary Artery Disease / prevention & control
  • Coronary Restenosis / prevention & control*
  • Drug-Eluting Stents / adverse effects
  • Drug-Eluting Stents / statistics & numerical data*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Risk Factors
  • Sirolimus / therapeutic use*
  • Treatment Outcome*

Substances

  • Immunosuppressive Agents
  • Sirolimus